Video Experimental Relacionado
Updated: May 12, 2026
12:24
Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Mecanismos de la inhibición del fármaco de las moléculas de señalización
Judith S Sebolt-Leopold1, Jessie M English
1Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA.
Nature
|May 26, 2006
Resumen
Las nuevas terapias moleculares dirigidas al cáncer ofrecen un cambio de paradigma, alejándose de los medicamentos no específicos. A pesar de los desafíos en la orientación de vías complejas, estos agentes emergentes muestran avances terapéuticos significativos contra varios tipos de cáncer humano.
Área de la Ciencia:
- Oncología Oncología.
- Farmacología Farmacología.
- Biología Molecular Biología Molecular
Sus antecedentes:
- La terapia del cáncer está cambiando hacia agentes molecularmente dirigidos, reduciendo la dependencia de los medicamentos citotóxicos tradicionales.
- El desarrollo de nuevos fármacos contra el cáncer dirigidos a vías moleculares específicas representa un avance significativo.
- Los desafíos permanecen en la comprensión y la orientación de las vías complejas de transducción de señales involucradas en el cáncer.
Objetivo del estudio:
- Para resaltar el cambio de paradigma en la terapia del cáncer impulsado por agentes molecularmente dirigidos.
- Discutir los desafíos y avances en el diseño de regímenes de tratamiento efectivos para los medicamentos anticancerígenos emergentes.
- Subrayar el potencial terapéutico de los nuevos agentes a pesar de las incertidumbres en sus mecanismos precisos de acción.
Principales métodos:
- Revisión de los agentes molecularmente dirigidos emergentes en la terapia del cáncer.
- Análisis de las vías de transducción de señales implicadas en el tratamiento del cáncer.
- Evaluación de los avances terapéuticos y desafíos asociados con los nuevos compuestos anticancerígenos.
Principales resultados:
- Los agentes dirigidos molecularmente representan un cambio de paradigma, minimizando el daño a las células sanas.
- Mayor diversidad de objetivos para los fármacos anticancerígenos de nueva generación.
- Se observaron avances terapéuticos significativos en un amplio espectro de cánceres humanos.
Conclusiones:
- Los agentes dirigidos emergentes están revolucionando los paradigmas de tratamiento del cáncer.
- A pesar de las complejidades en la orientación de múltiples vías, estos agentes demuestran una eficacia considerable.
- La investigación continua sobre los mecanismos moleculares optimizará aún más la terapia personalizada contra el cáncer.
Videos de Conceptos Relacionados
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...